Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| University of Basel | OTHER |
| Psychiatric Hospital of the University of Basel | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Electronic dispensers for polypharmacy are used in home care to assist patients with their medication management and to improve adherence. Opioid dependent patients with substitution therapy often exhibit multiple risk factors for non-adherence. The increase of both the age and associated comorbidities in this population demand for innovative solutions to optimize medication management. The investigators developed a novel medication supply model with an automated electronic medication dispenser to simultaneously assist opioid dependent patients with their medication and objectively monitor their adherence. This study aims to demonstrate the feasibility of the new supply model.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| electronic medication dispenser | Experimental | An Automatic Tablet Dispensing and Packaging System is used to repack all solid oral prescription medications for each participant into unit-of-dose pouches. Every participant receives a roll with pouches for 14-28 days loaded into a dispenser installed at their homes. The electronic medication dispenser is a remote controlled, electronic medication management aid reminding the patients with acoustic alerts to take their medication. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| electronic medication dispenser (medido) | Device | Automated dispense of medication through an electronic dispenser |
|
| Measure | Description | Time Frame |
|---|---|---|
| Taking Adherence (Number of days with correctly dispensed pouches (%) | Number of days with correctly dispensed pouches (%) | continuous, up to 24 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Timing adherence (number of correctly dispensed pouches within predefined time-frame (%) | number of correctly dispensed pouches within predefined time-frame (%) | continuous, up to 24 weeks |
| Patients' specific routine parameters according to condition(s) of participant (composite outcome) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Kurt Hersberger, Prof. MD | University Hospital, Basel, Switzerland | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Outpatient addiction service, University Psychiatric Clinics | Basel | Switzerland |
Not provided
| ID | Term |
|---|---|
| D019966 | Substance-Related Disorders |
| ID | Term |
|---|---|
| D064419 | Chemically-Induced Disorders |
| D001523 | Mental Disorders |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Individual clinical outcomes, eg blood pressure, blood sugar, HIV count... |
| up to 24 weeks |
| Psychological distress | SCL-90R self-report questionnaire | inclusion, week 12, 24, 36 |
| Quality of Life | SF-12 self-report questionnaire | inclusion, weeks 3, 6, 9, 12, 15, 18, 21, 24, 36 |
| Satisfaction | self-report questionnaire, interview | week 12, 24, 36 |
| Instrumental Activities of Daily Living | Instrumental Activities of Daily Living Scale (Lawton-Brody) | inclusion, week 12, 24, 36 |
| Cognitive Impairment | Montreal Cognitive Assessment | inclusion, week 12, 24, 36 |